| 000 | 01541 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513230113.0 | ||
| 264 | 0 | _c20011226 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(20010101)91:1<66::aid-cncr9>3.0.co;2-p _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, L | |
| 245 | 0 | 0 |
_aRisk of prostate carcinoma death in patients with lymph node metastasis. _h[electronic resource] |
| 260 |
_bCancer _cJan 2001 |
||
| 300 |
_a66-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma _xmortality |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphatic Metastasis _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProstatectomy |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmortality |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aZincke, H | |
| 700 | 1 | _aBlute, M L | |
| 700 | 1 | _aBergstralh, E J | |
| 700 | 1 | _aScherer, B | |
| 700 | 1 | _aBostwick, D G | |
| 773 | 0 |
_tCancer _gvol. 91 _gno. 1 _gp. 66-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(20010101)91:1<66::aid-cncr9>3.0.co;2-p _zAvailable from publisher's website |
| 999 |
_c11088442 _d11088442 |
||